AKT1 and breast cancer: For example, the HR-positive BC patients receiving neoadjuvant chemotherapy, cancer cells often overexpress DNAJC12 to resist DOX through the DNAJC12-HSP70-Akt signaling axis, inhibiting ferroptosis and apoptosis, and causing drug resistance [226].